Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 2
2(50.0%)
N/A
1(25.0%)
Phase 4
1(25.0%)
4Total
Phase 2(2)
N/A(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07473635Not ApplicableRecruiting

Perineural Incobotulinumtoxin-A for Complex Regional Pain Syndrome - An Open-label Feasibility Study

Role: collaborator

NCT05623111Phase 2Recruiting

Perineural Injections of Incobotulinumtoxin-A for Diabetic Neuropathic Pain of the Lower Extremities

Role: collaborator

NCT02284230Phase 2Withdrawn

The Effect of Liraglutide in Patients With Prediabetes and Kidney Failure

Role: collaborator

NCT01394341Phase 4Completed

Liraglutide Treatment to Patients With Severe Renal Insufficiency

Role: collaborator

All 4 trials loaded